Groowe Groowe / Newsroom / ENTX
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ENTX News

Entera Bio Ltd. Ordinary Shares

Rumi Therapeutics Announces Licensing Agreement With Enthorin Therapeutics to Advance RTX-7340, an IND-Ready PDE2 Inhibitor, for Fragile X Syndrome

businesswire.com
ENTX

Form 8-K

sec.gov
ENTX OGN MRK

Entera Appoints Global Research and Development Leader Dr. Juan Camilo Arjona Ferreira to Its Board of Directors

globenewswire.com
OGN ENTX MRK

Respiratory Infection Diagnostics Market Forecast 2025-2029 by Technology, Plex, Testing Site, Product, and Region | Multiplex and Point-of-Care Testing Unlock New Growth

globenewswire.com
QGEN CODX BDX BIOX TKO GTEC CUE BFC HOG FGEN ABT DXCM TMO DHR QDEL LH DGX SYK ALGN EXAS ILMN GOOG MSFT AMZN NVDA INTC AMD CRM IBM ORCL CSCO NFLX CMCSA PEP KO MCD DIS BA CAT GE XOM CVX PFE MRK JNJ BMY GILD AMGN REGN VRTX BIIB AZN SNY NVS TEVA BABA JD BIDU NTES PDD SIRI EA TTWO ADPT ALNY ASMB AXNX BCRX BEAM CDXS CGEN CHKP CLDX CRIS CTAS CYTK DAVA DECK DTIL EDIT ENTX EVTC EXEL FATE FCEL FLEX FORM FTNT FTV GALT GEN GNTX GRMN GSK HALO HAYW HBIO HIMX HOLX HTHT IDXX INCY INSM INTU IOVA ISRG JAZZ KDP KHC KLAC KODK LAKE LCID LRCX LSCC LULU LYFT MCHP MDLZ MELI MGM MNST MRVL MU NCLH NDSN NEO NET NI NKE NOC NOV NTAP NXPI OMC ON ORLY OSK OTIS PACB PAYX PCAR PCG PENN PERI PETS PGR PHG PI PINS PLAB PLUG PM PNW POOL POST PPG PRGS PRTA PSX PTC PTON PYPL QCOM QRVO RCL RDNT REG RGEN RIVN RL ROST RS RVSN RYAAY S SAN SBAC SBUX SCHW SE SEDG SEIC SITE SLAB SLM SMCI SNA SNOW SNPS SOFI SPNS SRPT SSNC STAG STX SWKS T TAL TCOM TDOC TEAM TECK TER TFX TGT TGS TIGR TLRY TM TMHC TNDM TNK TOL TOP TOST TPL TRMB TRMK TRP TSLA TSN TTD TTC TXN TXRH TYL U UAL ULTA UMC UNH UNP UPS URBN V VRSK VRSN VTR VTRS WDC WEC WEN WFC WGO WHR WMB WMT WST WU WYNN XBIT XCUR XENE XPO XRAY XYL YETI YUM ZBRA ZIM ZION ZTS

Entera Presents Markedly Enhanced Anabolic Effects of EB613 (First-in-Class Oral PTH(1-34) Tablet) in Postmenopausal Women with Osteoporosis at High Risk of Fracture and Showcases Phase 3 Design at ASBMR 2026 Annual Meeting

globenewswire.com
ENTX

Entera Bio Announces Additional Presentation of EB613 Phase 3 Study Design at the ASBMR 2026 Annual Meeting

globenewswire.com
ENTX

Form 8-K

sec.gov
ENTX GILD AMGN JAZZ FATE MRK OPK

Entera Appoints Global BioPharma Executive Laura Hamill to Its Board of Directors, Expanding Commercial Expertise

globenewswire.com
ENTX JAZZ FATE

Correction: Entera to Participate in Upcoming Fall Investor Conferences

globenewswire.com
ENTX

Entera to Participate in Upcoming Fall Investor Conferences

globenewswire.com
ENTX